Shant Apelian//LinkedIn
Apr 29, 2026, 10:19
Shant Apelian: Impact of Caffeine on Neurodevelopmental Outcomes in Preterm Infants
Shant Apelian, Postdoctoral Researcher in Obstetrics and Gynecology at Yale University, shared a post on LinkedIn about a paper shared in Pediatrics and Neonatology:
“Thrilled to share our new publication in Pediatrics and Neonatology
‘Impact of caffeine on neurodevelopmental outcomes in preterm infants: A systematic review and meta-analysis’
We found that caffeine, as a medication in preterm infants, might improves motor and cognitive outcomes and reduces the risk of cerebral palsy, with no significant effect on language development.
Always happy to learn and grow in the research field!”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 29, 2026, 12:34Inclusive Guidance for People Exploring Donor Conception – London Sperm Bank
-
Apr 29, 2026, 12:07International Donor Conception Awareness Day – HFEA
-
Apr 29, 2026, 11:56Infertility Treatment Access as NIAW2026 Comes to a Close – ASRM
-
Apr 29, 2026, 11:31RCOG Opens New Webinar Series to Support O and G Surgical Skills Training
-
Apr 29, 2026, 11:22Pauline Saint Martin: Victims of Violence, Screening and Health Consequences in Focus in New Webinar
-
Apr 29, 2026, 10:56Christopher Robinson: Isolated Severe Systolic Hypertension During Delivery Admission and Maternal Outcomes
-
Apr 29, 2026, 10:49Risks, Costs and Evidence Behind Fertility Add-Ons – HFEA
-
Apr 29, 2026, 10:29Estradiol Levels and Embryo Development in IVF – RBMO
-
Apr 29, 2026, 10:25Great News for ESHRE2026 Attendees, Scientific Speed Dating is Back – ESHRE